Overview

Ex Vivo Cultured Bone Marrow Derived Allogenic MSCs in AMI

Status:
Completed
Trial end date:
2012-08-01
Target enrollment:
Participant gender:
Summary
This clinical trial aims to find out the safety and efficacy of adult mesenchymal stem cells in patients with myocardial infarction.
Phase:
Phase 1/Phase 2
Details
Lead Sponsor:
Stempeutics Research Pvt Ltd
Treatments:
Plasma-lyte 148